Enrique Alvarez, MD/PhD is head of the Neuroimmunology Section and Medical Director of the Rocky Mountain MS Center. He is a Professor of Neurology and also serves as Vice Chair of Clinical Research for the Department. Dr. Alvarez is a graduate of the Medical Scientist Training program at the University of 麻豆传媒高清 School of Medicine. He completed his neurology residency and neuroimmunology fellowship at Washington University in St. Louis where he also received a master's degree in clinical investigation. Dr. Alvarez’s research interests and projects include clinical trials, use of real-world data to evaluate therapeutics, and fluid and imaging biomarkers for multiple sclerosis.

Jeffrey Bennett, MD/PhD is a Professor of Neurology and Ophthalmology and Vice Chair of Basic Research for the Department of Neurology. He is  a member of the Immunology and Neuroscience programs and holds the Gertrude Gilden Professorship. Dr. Bennett received his undergraduate degrees in biochemistry and philosophy at Case Western Reserve University. He then received his MD and PhD at Stanford University. Dr. Bennett directs research programs on optic neuritis, demyelinating disorders, and ocular inflammatory diseases. He also maintains active specialty practices in neuro-ophthalmology and demyelinating diseases including MS, NMOSD, and MOGAD.

As a clinician-scientist, Dr. Bennett is devoted to understanding the effects of autoimmune demyelination on the nervous system and using this knowledge to transform the care of affected individuals. In the clinic, Dr. Bennett directs clinical trials on new therapies for optic neuritis and neuromyelitis optica. In the laboratory, Dr. Bennett is working to identify the targets of the immune response in neuromyelitis optica and multiple sclerosis and is working to understand the mechanisms by which these disorders cause damage to the nervous system. His laboratory uses multiple experimental methods to evaluate the targets and action of antibodies derived from immune cells in the spinal fluid of neuromyelitis optica and multiple sclerosis patients, and employs state-of-the art techniques to establish the role of these antibodies in causing disease.

Robert Gross, MD/MSCR is an Assistant Professor of Neurology and Program Director for the Neuroimmunology Fellowship Program. Dr. Gross attended college at Columbia University and medical school at New York University. He completed internship in internal medicine and neurology residency at Brown University before fellowship in neuroimmunology and a master's degree in clinical research at the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mt. Sinai. Dr. Gross sees patients with multiple sclerosis and related disorders of the central nervous system. He divides his time between patient care, teaching, and clinical research. Research interests include the identification of biomarkers associated with treatment response in multiple sclerosis and the establishment of prospective databases to aid in prognostication.

Ryan Kammeyer, MD/MS is an Assistant Professor of Neurology and Pediatrics. Dr. Kammeyer completed child neurology residency and neuroimmunology fellowship at the University of 麻豆传媒高清. His research interests include improving the differentiation of autoimmune and infectious encephalitis through clinical features, evaluation of biomarkers of disease activity in autoimmune encephalitis, and evaluation of neuro-rheumatologic diseases such as neuropsychiatric lupus, with a goal of improving diagnosis, prevention, and treatment of these rare diseases. He is also researching neuropsychological and socioeconomic outcomes in pediatric onset multiple sclerosis and evaluation and treatment of regression in patients with Down syndrome.

Amanda Piquet, MD is an Associate Professor of Neurology. She is Director of the Autoimmune Neurology Program and holds the Céline Dion Foundation Endowed Chair in Autoimmune Neurology. Dr. Piquet serves as Associate Program Director for the Neuro-Infectious Diseases / Autoimmune Neurology Fellowship Program. Dr. Piquet completed her residency training at the Harvard Medical School’s program at Massachusetts General Hospital and Brigham and Women’s Hospital in Boston. After residency, she completed a fellowship in autoimmune neurology at the University of Utah. Her research and clinical interests include autoimmune and infectious encephalitis, neuro-rheumatology, and stiff person syndrome, among others. She is involved with quality improvement projects focused on the diagnosis and management of patients with acute encephalitis and developing biomarkers to better characterize clinical outcomes for patients with autoimmune neurological diseases.

Teri Schreiner, MD/MPH is an Associate Professor of Neurology and Pediatrics and currently serves as Program Director for the Child Neurology Residency. Dr. Schreiner received a BA in Anthropology from the University of Pennsylvania and an MPH from Yale University before spending several years as a healthcare consultant. She then attended medical school at the University of Rochester before completing her child neurology residency and neuroimmunology fellowship at the University of 麻豆传媒高清. She has interests in multiple sclerosis and neuroinfectious disease and was closely involved in the acute flaccid myelitis (AFM) cluster of cases that presented in the context of an Enterovirus D68 outbreak in 2014. Recent research efforts have included characterizing the 12 month outcomes of the children affected with AFM in 2014. She has lectured nationally on this topic and served as an international resource for providers with similar patients.

Anna Shah, MD is an Assistant Professor of Neurology. Dr. Shah serves as Associate Medical Director and Director of Patient Safety and Experience for the neurology practice at the University of 麻豆传媒高清 Hospital. Dr. Shah attended the University of Missouri - Kansas City for her undergraduate studies and medical school. She went on to complete neurology residency at the University of Michigan, where she served as chief resident in her final year. She completed her fellowship in neuroimmunology at the University of 麻豆传媒高清. She sees patients with multiple sclerosis and other related disorders of the nervous system. She has special interests in family planning and women's health in relation to multiple sclerosis and disease-modifying therapies.

Andrew Wolf, MD is an Assistant Professor of Neurology and Associate Program Director for the Neuroimmunology Fellowship Program. Dr. Wolf completed medical school, neurology residency, and neuroimmunology fellowship at the University of 麻豆传媒高清. His clinical practice is focused on inflammatory diseases of the central nervous system, including multiple sclerosis (MS) and other demyelinating diseases. His primary research interests are optimizing the selection, sequencing, and safety of disease-modifying therapies (DMTs) for MS. Specific interests include evaluating alternative dosing regimens for anti-CD20 DMTs, use of digital biomarkers to track disease progression, and inpatient neuroimmunology. He maintains an active interest in resident and fellow education and currently serves as faculty director for the neurology residency journal club.

Coming Soon

Coming Soon